New flu vaccine with extra H3 strain shows promise in early trial

NCT ID NCT06507553

First seen Nov 01, 2025 · Last updated Jun 11, 2026 · Updated 36 times

Summary

This study tested a new flu vaccine that includes an extra H3 virus strain, aiming to improve protection. About 400 healthy adults aged 18-49 and 60+ received either the new vaccine or a standard one. Researchers checked for side effects and measured immune responses over 3 weeks.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Investigational Site Number : 0360001

    Melbourne, Victoria, 3124, Australia

  • Investigational Site Number : 0360002

    Botany, New South Wales, 2019, Australia

  • Investigational Site Number : 0360003

    Southport, Queensland, 4222, Australia

  • Investigational Site Number : 0360004

    Sippy Downs, Queensland, 4556, Australia

  • Investigational Site Number : 0360005

    Morayfield, 4506, Australia

  • Investigational Site Number : 0360007

    Adelaide, South Australia, 5067, Australia

  • Investigational Site Number : 0360010

    Brookvale, New South Wales, 2100, Australia

  • Investigational Site Number : 0360011

    Miranda, New South Wales, 2228, Australia

  • Investigational Site Number : 0360012

    Maroubra, New South Wales, 2035, Australia

  • Investigational Site Number : 0360013

    Taringa, Queensland, 4068, Australia

Conditions

Explore the condition pages connected to this study.